Labarai
-
Sabuwar Dokar Ka'ida
1. Sabbin Dokokin Rijistar FDA don Kayan Kayan Kayan Kayan Aiki na Amurka Ba tare da Rijistar FDA ba Za a Haramta Daga Siyarwa. Bisa ga Zamantakewar Dokokin Kayayyakin Kayan Aiki na 2022, wanda Shugaba Biden ya sanya wa hannu a ranar 29 ga Disamba, 2022, duk kayan kwalliyar da aka fitar zuwa Amurka dole ne su kasance FDA-rejista...Kara karantawa -
2023 API ɗin 88th CINA
Bayani game da JYMed a 2023 API CHINA 【on-site】 Karkashin jagorancin Mataimakin Janar Manaja Zhi Qin, Shenzhen JYMed Technology Co., Ltd. (nan gaba ana kiranta da JYMed) sun halarci wannan babban nunin. JYMed ya nuna samfurori masu fa'ida Semaglutide, Liraglutide, Tirzepatide, O ...Kara karantawa -
Barka da saduwa da mu a nunin API a Qindao China JYMed stock: N4K32
Kara karantawa -
JYMed ya taru tare da ku a PCHi
Bayan shekaru biyu na sa rai, an gudanar da bikin baje kolin kayayyakin kwaskwarima na kasa da kasa na kasa da kasa da na gida da na gida (PCHi) a gidan baje kolin kayayyakin gargajiya na Guangzhou a ranar 15-17 ga Fabrairu, 2023.Kara karantawa -
Semeglutide API na Shenzhen JYMed yarda da farkon tsari na gida NMPA da kuma Rajista a US FDA (DMF No. 036009) tare da matsayi "A".
A cikin Mayu 2022, Shenzhen JYMed Technology Co., Ltd. (wanda ake magana da shi a matsayin JYMed peptide) ya gabatar da aikace-aikacen rajistar semaglutide API ga Hukumar Abinci da Magunguna ta Amurka (FDA) (lambar rajista DMF: 036009), Ya wuce bita na gaskiya, da matsayin da nake yanzu...Kara karantawa
